Data / Form D filings / AXIAL THERAPEUTICS, INC.
AXIAL THERAPEUTICS, INC.: Form D filings
AXIAL THERAPEUTICS, INC., a pharmaceuticals company in Woburn, MA, filed 9 Form D notices with the SEC between 2016 and 2025. The latest, on February 11, 2025, reports $19.4 million sold of a $22 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 TRADECENTER DRIVE, SUITE 6990, Woburn, MA, 01801
- Phone
- (781) 701-8484
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1691625
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | New notice | $22,000,000 | $19,379,799 | $2,620,201 | 29 | Jan 28, 2025 | sec.gov |
| Oct 27, 2023 | New notice | $24,000,000 | $11,054,030 | $12,945,970 | 35 | Oct 18, 2023 | sec.gov |
| Oct 25, 2021 | Amendment | $37,806,866 | $27,352,547 | $10,454,319 | 38 | May 11, 2021 | sec.gov |
| May 26, 2021 | New notice | $20,000,000 | $4,765,696 | $15,234,304 | 30 | May 11, 2021 | sec.gov |
| May 22, 2020 | New notice | $8,000,000 | $7,825,000 | $175,000 | 21 | May 7, 2020 | sec.gov |
| Jun 24, 2019 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 1 | Jun 18, 2019 | sec.gov |
| Nov 21, 2018 | New notice | $28,000,000 | $20,026,439 | $7,973,561 | 36 | Nov 9, 2018 | sec.gov |
| Jun 29, 2017 | Amendment | $19,150,000 | $19,150,000 | 16 | Nov 22, 2016 | sec.gov | |
| Dec 7, 2016 | New notice | $19,150,000 | $9,575,000 | $9,575,000 | 16 | Nov 22, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| SARAH K. MEIBUSCH | Director | |
| SCOTT C. BRUN | Director | |
| REBECCA C. SENTER | Executive Officer | |
| NORA C. FREY | Director | |
| A. STEWART CAMPBELL | Executive Officer, Director | |
| Michele C. Cucullu | Director | |
| SARKIS K. MAZMANIAN | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Feb 10, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AXIAL THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.